Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151307 · ClinicalTrials.gov registry record · Phase 2
Effects of Cerebral Oxygen Saturation on Neuropsychological Outcomes
A Phase 2 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 2
- Development phase
- 200
- Enrollment target
NCT00151307 is a Phase 2 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 200 participants.
The verdict
NCT00151307, a Phase 2 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the effects of maintaining adequate cerebral oxygen saturation (over 40%) on patients undergoing cardiac surgery. Effects on neuropsychological outcome, length of ICU stay, and length of hospital stay will be measured.
Interventions
- DEVICE INVOS cerebral oximeter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2001-02 |
| Est. Completion | 2007-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00151307
The ClinicalTrials.gov registry entry for NCT00151307 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which INVOS cerebral oximeter is the first listed.
NCT00151307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00151307 about?
NCT00151307 is a clinical study titled "Effects of Cerebral Oxygen Saturation on Neuropsychological Outcomes". The purpose of this study is to evaluate the effects of maintaining adequate cerebral oxygen saturation (over 40%) on patients undergoing cardiac surgery. Effects on neuropsychological outcome, length of ICU stay, and length of hospital stay will be measured.
What is the current status of trial NCT00151307?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 200 participants. The study started on 2001-02. Estimated completion is 2007-04.
What interventions are being tested in trial NCT00151307?
The interventions under investigation include: INVOS cerebral oximeter (DEVICE).
Who is sponsoring clinical trial NCT00151307?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.